iBio, Inc. (IBIO)

iBio, Inc. Statistics

Total Valuation

iBio, Inc. has a market cap or net worth of $20.04 million. The enterprise value is $13.43 million.

Market Cap	20.04M
Enterprise Value	13.43M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

iBio, Inc. has 9.15 million shares outstanding. The number of shares has increased by 610.35% in one year.

Current Share Class	9.15M
Shares Outstanding	9.15M
Shares Change (YoY)	+610.35%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	16.74%
Float	8.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	71.20
Forward PS	n/a
PB Ratio	1.07
P/TBV Ratio	1.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	76.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.25.

Current Ratio	3.37
Quick Ratio	3.18
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-77.03

Financial Efficiency

Return on equity (ROE) is -92.74% and return on invested capital (ROIC) is -37.33%.

Return on Equity (ROE)	-92.74%
Return on Assets (ROA)	-31.43%
Return on Capital (ROIC)	-37.33%
Revenue Per Employee	$10,938
Profits Per Employee	-$1.45M
Employee Count	16
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.92% in the last 52 weeks. The beta is -3.37, so iBio, Inc.'s price volatility has been lower than the market average.

Beta (5Y)	-3.37
52-Week Price Change	-57.92%
50-Day Moving Average	2.42
200-Day Moving Average	2.02
Relative Strength Index (RSI)	37.39
Average Volume (20 Days)	83,708

Short Selling Information

The latest short interest is 307,797, so 3.36% of the outstanding shares have been sold short.

Short Interest	307,797
Short Previous Month	85,911
Short % of Shares Out	3.36%
Short % of Float	3.82%
Short Ratio (days to cover)	1.46

Income Statement

In the last 12 months, iBio, Inc. had revenue of $175,000 and -$23.15 million in losses. Loss per share was -$4.07.

Revenue	175,000
Gross Profit	175,000
Operating Income	-15.64M
Pretax Income	-23.16M
Net Income	-23.15M
EBITDA	-14.75M
EBIT	-15.64M
Loss Per Share	-$4.07

Balance Sheet

The company has $11.04 million in cash and $4.43 million in debt, giving a net cash position of $6.61 million or $0.72 per share.

Cash & Cash Equivalents	11.04M
Total Debt	4.43M
Net Cash	6.61M
Net Cash Per Share	$0.72
Equity (Book Value)	17.75M
Book Value Per Share	2.06
Working Capital	8.24M

Cash Flow

In the last 12 months, operating cash flow was -$16.93 million and capital expenditures -$210,000, giving a free cash flow of -$17.14 million.

Operating Cash Flow	-16.93M
Capital Expenditures	-210,000
Free Cash Flow	-17.14M
FCF Per Share	-$1.87

Margins

Gross Margin	100.00%
Operating Margin	-8,935.43%
Pretax Margin	-8,204.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-35,252.00%

Dividends & Yields

iBio, Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-610.35%
Shareholder Yield	-610.35%
Earnings Yield	-115.53%
FCF Yield	-85.54%

Analyst Forecast

The average price target for iBio, Inc. is $4.30, which is 96.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.30
Price Target Difference	96.35%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	168.88%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 29, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 29, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

iBio, Inc. has an Altman Z-Score of -18.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.88
Piotroski F-Score	3